Hypoglycaemic Agents

2021 ◽  
pp. 811-811
Keyword(s):  
Diabetes ◽  
2018 ◽  
Vol 67 (Supplement 1) ◽  
pp. 2293-PUB ◽  
Author(s):  
VEERANNA KARADI ◽  
DILIP PAWAR ◽  
SARAH JABEEN ◽  
SANDEEP S. ◽  
SAPTARSHI BOSE ◽  
...  

2017 ◽  
Vol 7 (3) ◽  
Author(s):  
Akhlesh K. Jain ◽  
Parasuraman Mohan ◽  
Sunil K. Jain ◽  
Karthikeyan Kesavan

1964 ◽  
Vol 16 (10) ◽  
pp. 677-689 ◽  
Author(s):  
D. F. HAYMAN ◽  
G. B. JACKMAN ◽  
V. PETROW ◽  
O. STEPHENSON ◽  
A. M. WILD
Keyword(s):  

2015 ◽  
Vol 2015 ◽  
pp. 1-10 ◽  
Author(s):  
Prasanna A. Datar ◽  
Sonali R. Jadhav

Pyrazole-3-one compounds were designed on the basis of docking studies of previously reported antidiabetic pyrazole compounds. The amino acid residues found during docking studies were used as guidelines for the modification of aromatic substitutions on pyrazole-3-one structure. Depending on the docking score, the designed compounds were selectively prioritized for synthesis. The synthesized compounds were subjected to in vivo hypoglycemic activity using alloxan induced diabetic rats and metformin as a standard. Compound 4 having sulphonamide derivative was found to be the most potent compound among the series.


Sign in / Sign up

Export Citation Format

Share Document